홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Doxorubicin Hydrochloride → Doxorubicin

HRID 550325
노트
인쇄 미리보기

반응식

HRID 550325 반응식
C(C=C(C#N)C([O-])=O)CCC.[CH3:12][C@@H:13]1[O:18][C@@H:17]([O:19][C@@H:20]2[C:25]3=[C:26]([OH:43])[C:27]4[C:39](=[O:40])[C:38]5[C:33](=[CH:34][CH:35]=[CH:36][C:37]=5[O:41][CH3:42])[C:31](=[O:32])[C:28]=4[C:29]([OH:30])=[C:24]3[CH2:23][C@@:22]([OH:48])([C:44]([CH2:46][OH:47])=[O:45])[CH2:21]2)[CH2:16][C@H:15]([NH2:49])[C@@H:14]1[OH:50].Cl>Cl.O>[CH3:12][C@@H:13]1[O:18][C@@H:17]([O:19][C@@H:20]2[C:25]3=[C:26]([OH:43])[C:27]4[C:39](=[O:40])[C:38]5[C:33](=[CH:34][CH:35]=[CH:36][C:37]=5[O:41][CH3:42])[C:31](=[O:32])[C:28]=4[C:29]([OH:30])=[C:24]3[CH2:23][C@@:22]([OH:48])([C:44]([CH2:46][OH:47])=[O:45])[CH2:21]2)[CH2:16][C@H:15]([NH2:49])[C@@H:14]1[OH:50]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 443939Doxorubicin HydrochlorideHCID 53630043Butylcyanoacrylate

생성물 1

HCID 31703Doxorubicin

시약·촉매·용매 2

HCID 313Hydrochloric Acid용매HCID 962Water용매

실험 절차

100 μl of n-butylcyanoacrylate monomer was added to 1% dextran solution in 8 mL of 0.01 M HCl under constant stirring at 600 rpm. Doxorubicin hydrochloride powder 50 mg was dissolved in 2 mL of distilled water and after 40 minutes the solution was added to the reaction flask. After 4 hours the pH of the nanoparticle suspension was adjusted at 7 and filtered through 0.8 μm membrane filter (Nuclepore Track-Etch membrane, Whatman, USA). The doxorubicin-loaded nanoparticle suspension was kept in a refrigerator at 4° C.

후처리

  1. additionwas added to the reaction flask
  2. filtrationfiltered through 0.8 μm membrane
  3. filtrationfilter (Nuclepore Track-Etch membrane, Whatman, USA)
  4. customwas kept in a refrigerator at 4° C.

출처 및 근거

ORD 기록
ord-b591766626c745f0a9a57ca2344fd3c7
출처 데이터셋
uspto-grants-2011_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07947308B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트